DERMATITIS, ATOPIC

This study is monitoring the safety and effectiveness of the approved eczema medication Cibinqo (abrocitinib) in real-world medical practice in Korea. It will follow about 1,100 patients, aged 12 and older with moderate to severe atopic dermatitis, for approximately one year afte…

This study is testing an investigational drug called JNJ-95597528 to see if it can reduce the skin rash and severe itching of moderate-to-severe eczema (atopic dermatitis). About 180 adult participants will receive either the drug or a placebo for 12 weeks to compare effectivenes…

This study is observing how well the oral medication abrocitinib works for people with moderate-to-severe eczema (atopic dermatitis) in real-world clinics. It focuses on about 150 patients aged 12 and older who did not get enough relief or could not tolerate up to two previous bi…

This study aims to understand the long-term safety and effectiveness of an investigational drug called amlitelimab for people with moderate to severe eczema (atopic dermatitis). About 900 participants aged 12 and older will receive the drug as a regular injection for up to 5 year…

This study is testing an investigational injection called amlitelimab for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that hasn't improved enough with other advanced treatments like biologics or JAK inhibitor pills. About 390 participants will rece…

This study is testing an experimental drug called 611 for teenagers with moderate-to-severe atopic dermatitis (eczema). It aims to see if the drug, given as an injection, can significantly clear skin and reduce itching compared to a placebo. The trial will involve 180 Chinese ado…

This study aims to observe how patients with moderate-to-severe atopic dermatitis (eczema) respond to the medication abrocitinib in real-world, everyday clinical practice. It will follow 200 patients aged 12 and older who are newly prescribed this medication by their doctor. Rese…

This study aims to understand how common eczema treatments, including antibiotics and bleach baths, change the community of bacteria living on the skin. Researchers will observe 130 healthy volunteers and people with moderate-to-severe eczema over one year, collecting skin sample…